{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:13Z","timestamp":1761541093361,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinimag.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T08:30:38Z","timestamp":1339144238000},"page":"865-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation"],"prefix":"10.1016","volume":"36","author":[{"given":"Jeanne C.","family":"Lammering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis K.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.clinimag.2012.01.011_bb0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0010","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1046\/j.1538-7836.2003.00270.x","article-title":"Heparin-induced thrombocytopenia","volume":"1","author":"Chong","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.clinimag.2012.01.011_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5","article-title":"Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution","volume":"56","author":"Nand","year":"1997","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.clinimag.2012.01.011_bb0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1378\/chest.08-2830","article-title":"Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management","volume":"135","author":"Shantsila","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.clinimag.2012.01.011_bb0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/hrt.2008.160549","article-title":"Thrombotic events in patients with antiplatelet factor 4\/heparin antibodies","volume":"95","author":"Mattioli","year":"2009","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.clinimag.2012.01.011_bb0035","first-page":"255","article-title":"Heparin-induced thrombocytopenia and thrombosis","volume":"36","author":"Patel","year":"2007","journal-title":"Am J Orthop"},{"issue":"4","key":"10.1016\/j.clinimag.2012.01.011_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"164","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0045","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2002-07-2201","article-title":"The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study","volume":"101","author":"Girolami","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clinimag.2012.01.011_bb0050","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.clinimag.2012.01.011_bb0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmrv.2006.05.001","article-title":"Testing for heparin-induced thrombocytopenia antibodies","volume":"20","author":"Warkentin","year":"2006","journal-title":"Transfus Med Rev"},{"issue":"6","key":"10.1016\/j.clinimag.2012.01.011_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lab.2005.08.003","article-title":"Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?","volume":"146","author":"Warkentin","year":"2005","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.clinimag.2012.01.011_bb0065","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1002\/jhm.512","article-title":"A fatal case of heparin-induced thrombocytopenia and thrombosis","volume":"5","author":"Mathews","year":"2010","journal-title":"J Hosp Med"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"issue":"S5","key":"10.1016\/j.clinimag.2012.01.011_bb0075","first-page":"9","article-title":"Clinical presentation of heparin-induced thrombocytopenia","volume":"35","author":"Warkentin","year":"1998","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.clinimag.2012.01.011_bb0080","first-page":"132","article-title":"Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis: a retrospective analysis of 408 patients","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.clinimag.2012.01.011_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1027325002276","article-title":"Heparin-induced thrombocytopenia. patient profiles and clinical manifestations","volume":"1","author":"Spencer","year":"2000","journal-title":"J of Thrombosis and Thrombolysis"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinimag.2012.01.011_bb0095","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707112000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707112000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:40:56Z","timestamp":1760269256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707112000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0899707112000174"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2012.01.011","relation":{},"ISSN":["0899-7071"],"issn-type":[{"type":"print","value":"0899-7071"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2012.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}